Document Detail


The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review.
MedLine Citation:
PMID:  23051659     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Data from randomized clinical trials and epidemiological evidence identify systemic hypertension as the second most common modifiable risk factor for chronic kidney disease (CKD) progression after diabetes mellitus. CKD may progress silently over the years and early diagnosis and control of hypertension is of major importance in delaying renal function decline. Recent guidelines for the treatment of hypertension suggest the use of a variety of antihypertensive drugs in order to achieve the desired blood pressure levels. Renin-angiotensin system inhibitors have been undoubtedly studied the most and are suggested by guidelines and experts as first choice in patients with hypertension and renal injury, particularly in those with diabetes, as they have repeatedly shown to significantly reduce proteinuria. Other classes of antihypertensive drugs have been studied to a lesser extent and they have their own unique properties and effects. However, it is now common knowledge that adequate blood pressure control is the most important factor for the preservation of renal function, so every drug that effectively lowers hypertension is believed to be renoprotective. The present article will review the latest data on the role and properties of each class of antihypertensive drugs on CKD.Hypertension Research advance online publication, 11 October 2012; doi:10.1038/hr.2012.157.
Authors:
Anastasia G Ptinopoulou; Maria I Pikilidou; Anastasios N Lasaridis
Related Documents :
17369519 - Improvement in functional ambulation as a therapeutic effect of peroneal nerve stimulat...
17011799 - The ethics of excluding women who become pregnant while participating in clinical trial...
23752749 - Formulation, development, and evaluation of floating pulsatile drug delivery system of ...
23371489 - Mephedrone and methylenedioxypyrovalerone (mdpv), major constituents of "bath salts," p...
16036079 - Intravenous bisphosphonate therapy for osteoporosis: where do we stand?
16377139 - Large clinical trials in epilepsy: funding by the nih versus pharmaceutical industry.
19925599 - Drug-induced angioedema without urticaria: prevalence and clinical features.
18471899 - Antipsychotic drug action: antagonism, inverse agonism or partial agonism.
25028539 - Associations between the 2007 medicare reimbursement reduction for bone mineral density...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-11
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  -     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Nephrology and Hypertension, First Department of Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cilnidipine regulates glucose metabolism and levels of high-molecular adiponectin in diet-induced ob...
Next Document:  Characterization and manipulation of foamy virus membrane interactions.